South Texas Blood & Tissue Center to Implement 3 Integrated Donor Systems
DENVER, Jan. 27 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has licensed its eDonor(R), ElDorado Donor(TM), and Donor Doc(TM) integrated donor management systems to South Texas Blood & Tissue Center (STBTC) of San Antonio, Texas, one of the top ten donor centers in the United States. Terms of the agreement were not disclosed.
Dr. Norman Kalmin, President, CEO and Medical Director for South Texas Blood & Tissue Center, stated, "Wyndgate has a solid reputation for developing quality blood bank software systems. Their recent release, ElDorado Donor, offers STBTC technology and robust functionality that will create cost-saving efficiencies and provide us tools that can improve blood safety during the manufacturing process."
Dr. Kalmin continued, "Wyndgate Technologies has provided us with a comprehensive business solution which addresses the complex needs of our organization. In addition to implementing ElDorado Donor in our collection facility, eDonor will offer our staff effective tools to improve communication with donors and increase donation frequency, while Donor Doc health history questionnaire will automate our donor pre-qualification process."
ElDorado Donor is a comprehensive donor management system which has been developed as part of an integrated modular system specifically designed for donor centers and hospitals. It was designed to increase efficiency and help enhance blood safety during the manufacture of blood products for transfusion, and combines system management, donor management tools, laboratory testing, manufacturing processes and distribution to allow an information stream to flow from donation to final distribution.
eDonor is a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospital based blood centers. eDonor unites flexible list management tools with multiple communication channels to increase donor retention and donation frequency, and supports the development and deployment of sophisticated donor loyalty programs.
ElDorado Donor Doc is an electronic health history questionnaire and physical exam tracking system which assists blood centers in screening donors by capturing medical and physical examination information. The software identifies donor responses where additional staff investigation is necessary and can help blood centers prevent release of products from unsuitable donors.
Thomas F. Marcinek, President and COO for Global Med Technologies, commented, "As one of the most prominent blood and tissue donation centers in the United States, South Texas Blood & Tissue Center's decision to implement our comprehensive donor systems demonstrates great confidence in Global Med. We are very pleased to have been chosen to provide our innovative solutions to their donor center. Our objective is to develop products that help our customers improve their businesses so they may provide the best possible service to their clients and communities. We have enjoyed working with STBTC in the past and look forward to a long relationship into the future."
Mick Ruxin, M.D., Chairman and CEO of Global Med Technologies, stated, "South Texas Blood & Tissue Center's decision to turn to Global Med Technologies for a multi-system solution to deliver high quality blood donor management services, together with cost-saving efficiencies, is very much in line with the President's program of utilizing health care information technology in order to lower health care costs and provide improved services. We believe that the great value-added contributions of our medical information technology will be even more recognized as the President's strategy is implemented and becomes policy."
About South Texas Blood & Tissue Center
South Texas Blood & Tissue Center has been a leading partner in the growth of a vigorous health care industry since January, 1974. Formerly the South Texas Regional Blood Bank, STBTC was incorporated as a non-profit community blood bank. Today, the South Texas Blood & Tissue Center serves over 100 hospitals and clinics in 43 South Texas counties. In addition to recruiting, collecting, processing, testing and distributing blood components, STBTC operates a certified tissue bank, houses the Texas Cord Blood Bank and also serves as a National Marrow Donor Program registration site.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international medical software company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.
Global Med's domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved